Association between Endothelial nitric oxide synthase and Hepatic lipase gene polymorphisms with the risk of coronary artery disease in Southern Iran population – A case control study. (1st March 2021)

• Record Type: Journal Article
• Authors: Seyedian, Seyed Masoud; Bijanzadeh, Mahdi; Ahmadi, Farzaneh; Haghighizadeh, Mohammad Hosein
• Is Part Of: Nucleosides, nucleotides & nucleic acids. Volume 40:Number 4(2021)
• Page Start: 423
• Page End: 433
• Publication Date: 2021-03-01
• Subjects: Cardiac disorder -- candidate genes -- restriction fragment length polymorphism; Nucleosides -- Periodicals; Nucleotides -- Periodicals; Nucleic acids -- Periodicals; 572.8
• DOI: 10.1080/15257770.2021.1892130
• Languages: English
• ISSNs: 1525-7770

Abstract

Abstract: Coronary artery disease is a multifactorial genetic disease caused by the interaction between genetic and environmental factors. Angiography is the gold standard method for the diagnosis and determining the stage of cardiac disorder. The rs1800588 at the Hepatic Lipase gene and rs1799983 at the endothelial nitric oxide synthase (eNOS) gene are two candidate SNP that result in increased risk of this disease. The aim of this study was to find out the associations of the two mentioned polymorphisms with angiographically proven coronary artery patients in a southern Iranian population. In this study, this two polymorphisms in 287 patients and 229 matched controls were confirmed by angiography and analyzed. Genotype analysis was carried out by PCR and RFLP. Data showed that a significant difference for the eNO S gene polymorphism ( p = 0.004) and a non-significant difference for the Hepatic lipase polymorphism ( p = 0.261) and increasing severity of angiographic evidences of coronary artery disease were observed. Conclusively the significant association of the G894T with the narrowing of two or three coronary vessels of this patients in an Iranian population have been detected.